A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fed Conditions in Healthy Adult Volunteers

Clinical trial NCT06289933 · COMPLETED

Trial details

NCT number: NCT06289933
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type2 Diabetes Mellitus

Start date: 2024-03-05
Primary completion: 2024-04-03
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.